BMJ 1999;318:939 ( 3 April )

Letters

Vitamin A for treating shigellosis

    Study did not prove benefit
    Authors' reply

Study did not prove benefit

The first 150 words of the full text of this article appear below.

EDITOR---Hossain et al conclude that vitamin A along with standard antibiotic reduces the severity of acute shigellosis and that vitamin A supplementation should be added to the standard treatment for acute shigellosis.1 We disagree with those conclusions.

The benefit of vitamin A as adjuvant treatment for shigellosis can be judged only in a study in which patients receive adequate antimicrobial treatment.2 In Hossain et al's study 64% of patients were infected with strains of shigella resistant to nalidixic acid, which was used to treat study patients. It is unclear how many patients were given an alternative effective antibiotic or when treatment was changed.

The inadequacy of antimicrobial treatment in this study is reflected in clinical cure rates of less than 50% in patients who did and did not receive vitamin A supplements. That is not acceptable as adequate antimicrobial treatment routinely achieves a cure rate of 65% or . . . [Full text of this article]
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Single dose vitamin A treatment in acute shigellosis in Bangladeshi children: randomised double blind controlled trial
Shahadat Hossain, Rabi Biswas, Iqbal Kabir, Shafique Sarker, Michael Dibley, George Fuchs, and Dilip Mahalanabis
BMJ 1998 316: 422-426. [Abstract] [Full Text] [PDF]

Access jobs at BMJ Careers
Whats new online at Student BMJ